Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices 5117

novel (H5N1) , tetanus, joining the teleconference at the USA toll- 1(800)CDC–INFO, Email [email protected]. The diphtheria, and acellular pertussis (Tdap) free, dial-in number is 1–866–659–0537 and Director, Management Analysis and Services ; hepatitis vaccines; new hexavalent the pass code is 9933701. Office, has been delegated the authority to vaccine work group; ; Background: The Advisory Board was sign Federal Register notices pertaining to in laboratory personnel; established under the Energy Employees announcements of meetings and other and vaccine supply. Recommendation votes Occupational Illness Compensation Program committee management activities, for both are scheduled for general recommendations, Act of 2000 to advise the President on a meningococcal vaccines, influenza, novel variety of policy and technical functions the Centers for Disease Control and influenza , yellow fever required to implement and effectively Prevention and the Agency for Toxic vaccine, smallpox vaccine, and human manage the new compensation program. Key Substances and Disease Registry. papillomavirus vaccines. Time will be functions of the Advisory Board include available for public comment. providing advice on the development of Elaine L. Baker, Agenda items are subject to change as probability of causation guidelines that have Director, Management Analysis and Services priorities dictate. been promulgated by the Department of Office, Centers for Disease Control and FOR FURTHER INFORMATION CONTACT: Health and Human Services (HHS) as a final Prevention. Stephanie Thomas, National Center for rule; advice on methods of dose [FR Doc. 2015–01765 Filed 1–29–15; 8:45 am] reconstruction, which have also been and Respiratory Diseases, BILLING CODE 4163–18–P CDC, 1600 Clifton Road NE., MS–A27, promulgated by HHS as a final rule; advice Atlanta, Georgia 30333, telephone 404/639– on the scientific validity and quality of dose estimation and reconstruction efforts being 8836; Email [email protected]. DEPARTMENT OF HEALTH AND Meeting is webcast live via the World Wide performed for purposes of the compensation Web; for instructions and more information program; and advice on petitions to add HUMAN SERVICES on ACIP please visit the ACIP Web site: classes of workers to the Special Exposure http://www.cdc.gov/vaccines/acip/ Cohort. Centers for Disease Control and index.html. In December 2000, the President delegated Prevention The Director, Management Analysis and responsibility for funding, staffing, and Services Office, has been delegated the operating the Advisory Board to HHS, which Disease, Disability, and Injury authority to sign Federal Register notices subsequently delegated this authority to CDC. Prevention and Control Special pertaining to announcements of meetings and NIOSH implements this responsibility for Emphasis Panel (SEP): Initial Review other committee management activities, for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and both the Centers for Disease Control and The meeting announced below Prevention and the Agency for Toxic will expire on August 3, 2015. Substances and Disease Registry. Purpose: The Advisory Board is charged concerns ‘‘Epi-Centers for the with (a) providing advice to the Secretary, Prevention of Healthcare-Associated Elaine L. Baker, HHS, on the development of guidelines , Antimicrobial Resistance and Director, Management Analysis and Services under Executive Order 13179; (b) providing Adverse Events-Multicenter Expansion Office, Centers for Disease Control and advice to the Secretary, HHS, on the of Current Investigation’’, Funding Prevention. scientific validity and quality of dose Opportunity Announcement (FOA) [FR Doc. 2015–01818 Filed 1–29–15; 8:45 am] reconstruction efforts performed for this CK11–0010501SUPP15, initial review. BILLING CODE 4163–18–P program; and (c) upon request by the Secretary, HHS, advise the Secretary on In accordance with Section 10(a)(2) of whether there is a class of employees at any the Federal Advisory Committee Act DEPARTMENT OF HEALTH AND Department of Energy facility who were (Pub. L. 92–463), the Centers for Disease exposed to radiation but for whom it is not HUMAN SERVICES Control and Prevention (CDC) feasible to estimate their radiation dose, and announces the aforementioned meeting: on whether there is reasonable likelihood Centers for Disease Control and that such radiation doses may have Time and Date: 12:00 p.m.–4:00 p.m., Prevention endangered the health of members of this February 23, 2015 (Closed). class. The Subcommittee for Dose Place: Teleconference. Subcommittee for Dose Reconstruction Reviews was established to Status: The meeting will be closed to the Reconstruction Reviews (SDRR), aid the Advisory Board in carrying out its public in accordance with provisions set Advisory Board on Radiation and duty to advise the Secretary, HHS, on dose forth in Section 552b(c)(4) and (6), Title 5 Worker Health (ABRWH or the reconstruction. U.S.C., and the Determination of the Director, Advisory Board), National Institute for Matters for Discussion: The agenda for the Management Analysis and Services Office, Subcommittee meeting includes the Occupational Safety and Health CDC, pursuant to Public Law 92–463. (NIOSH) following dose reconstruction program quality management and assurance activities: Matters For Discussion: The meeting will In accordance with section 10(a)(2) of Discussion of current findings from NIOSH include the initial review, discussion, and the Federal Advisory Committee Act and Advisory Board dose reconstruction evaluation of applications received in (Pub. L. 92–463), the Centers for Disease blind reviews; discussion of dose response to ‘‘Epi-Centers for the Prevention Control and Prevention (CDC), reconstruction cases under review including of Healthcare-Associated Infections, Pacific Proving Grounds, DuPont Deepwater Antimicrobial Resistance and Adverse announces the following meeting for the Works, and cases from Sets 14–18; the Oak Events-Multicenter Expansion of Current aforementioned subcommittee: Ridge sites (Y–12, K–25, Oak Ridge National Investigation’’, FOA CK11–0010501SUPP15’’. Time and Date: 10:30 a.m.–5:00 p.m., Laboratory, and Savannah River Site); plans Contact Person for More Information: Eastern Time, February 27, 2015. for dose reconstruction case reviews; and Gregory Anderson, M.S., M.P.H., Scientific Place: Audio Conference Call via FTS preparation of the Advisory Board’s next Review Officer, CDC, 1600 Clifton Road NE., report to the Secretary, HHS, summarizing Conferencing. Mailstop E60, Atlanta, Georgia 30333, Status: Open to the public, but without a the results of completed dose reconstruction Telephone: (404) 718–8833. The Director, public comment period. The public is reviews. The agenda is subject to change as welcome to submit written comments in priorities dictate. Management Analysis and Services Office, advance of the meeting, to the contact person Contact Person for More Information: has been delegated the authority to sign below. Written comments received in Theodore Katz, Designated Federal Officer, Federal Register notices pertaining to advance of the meeting will be included in NIOSH, CDC, 1600 Clifton Road NE., announcements of meetings and other the official record of the meeting. The public Mailstop E–20, Atlanta, Georgia 30333, committee management activities, for both is also welcome to listen to the meeting by Telephone (513) 533–6800, Toll Free the Centers for Disease Control and

VerDate Sep<11>2014 20:33 Jan 29, 2015 Jkt 235001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\30JAN1.SGM 30JAN1 asabaliauskas on DSK5VPTVN1PROD with NOTICES